CorneaGen innovates cornea care, from new medical devices and biologics to therapeutics and interventions. Founded in 2016, CorneaGen is backed by investors that include Flying L Partners, Petrichor Healthcare Capital Management, and Visionary Venture Fund and is headquartered in Seattle.